These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 37648081)

  • 1. Engineered short forms of perlecan enhance angiogenesis by potentiating growth factor signalling.
    Kim HN; Elgundi Z; Lin X; Fu L; Tang F; Moh ESX; Jung M; Chandrasekar K; Bartlett-Tomasetig F; Foster C; Packer NH; Whitelock JM; Rnjak-Kovacina J; Lord MS
    J Control Release; 2023 Oct; 362():184-196. PubMed ID: 37648081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perlecan and vascular endothelial growth factor-encoding DNA-loaded chitosan scaffolds promote angiogenesis and wound healing.
    Lord MS; Ellis AL; Farrugia BL; Whitelock JM; Grenett H; Li C; O'Grady RL; DeCarlo AA
    J Control Release; 2017 Mar; 250():48-61. PubMed ID: 28189628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perlecan and tumor angiogenesis.
    Jiang X; Couchman JR
    J Histochem Cytochem; 2003 Nov; 51(11):1393-410. PubMed ID: 14566013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tuning Recombinant Perlecan Domain V to Regulate Angiogenic Growth Factors and Enhance Endothelialization of Electrospun Silk Vascular Grafts.
    Jiang S; Yang N; Tan RP; Moh ESX; Fu L; Packer NH; Whitelock JM; Wise SG; Rnjak-Kovacina J; Lord MS
    Adv Healthc Mater; 2024 May; ():e2400855. PubMed ID: 38780418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Border patrol: insights into the unique role of perlecan/heparan sulfate proteoglycan 2 at cell and tissue borders.
    Farach-Carson MC; Warren CR; Harrington DA; Carson DD
    Matrix Biol; 2014 Feb; 34():64-79. PubMed ID: 24001398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Biomimetic Approach toward Enhancing Angiogenesis: Recombinantly Expressed Domain V of Human Perlecan Is a Bioactive Molecule That Promotes Angiogenesis and Vascularization of Implanted Biomaterials.
    Lin X; Tang F; Jiang S; Khamis H; Bongers A; Whitelock JM; Lord MS; Rnjak-Kovacina J
    Adv Sci (Weinh); 2020 Sep; 7(17):2000900. PubMed ID: 32995122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perlecan regulates developmental angiogenesis by modulating the VEGF-VEGFR2 axis.
    Zoeller JJ; Whitelock JM; Iozzo RV
    Matrix Biol; 2009 Jun; 28(5):284-91. PubMed ID: 19422911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The degradation of human endothelial cell-derived perlecan and release of bound basic fibroblast growth factor by stromelysin, collagenase, plasmin, and heparanases.
    Whitelock JM; Murdoch AD; Iozzo RV; Underwood PA
    J Biol Chem; 1996 Apr; 271(17):10079-86. PubMed ID: 8626565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perlecan heparan sulfate proteoglycan is a critical determinant of angiogenesis in response to mouse hind-limb ischemia.
    Qiang B; Lim SY; Lekas M; Kuliszewski MA; Wolff R; Osherov AB; Rudenko D; Leong-Poi H; Noyan H; Husain M; Tran K; Tryggvason K; Hedin U; Tran-Lundmark K; Strauss BH
    Can J Cardiol; 2014 Nov; 30(11):1444-51. PubMed ID: 25249499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peroxynitrite modifies the structure and function of the extracellular matrix proteoglycan perlecan by reaction with both the protein core and the heparan sulfate chains.
    Kennett EC; Rees MD; Malle E; Hammer A; Whitelock JM; Davies MJ
    Free Radic Biol Med; 2010 Jul; 49(2):282-93. PubMed ID: 20416372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perlecan, a modular instructive proteoglycan with diverse functional properties.
    Melrose J
    Int J Biochem Cell Biol; 2020 Nov; 128():105849. PubMed ID: 32947020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perlecan protein core interacts with extracellular matrix protein 1 (ECM1), a glycoprotein involved in bone formation and angiogenesis.
    Mongiat M; Fu J; Oldershaw R; Greenhalgh R; Gown AM; Iozzo RV
    J Biol Chem; 2003 May; 278(19):17491-9. PubMed ID: 12604605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angioinhibitory action of NK4 involves impaired extracellular assembly of fibronectin mediated by perlecan-NK4 association.
    Sakai K; Nakamura T; Matsumoto K; Nakamura T
    J Biol Chem; 2009 Aug; 284(33):22491-22499. PubMed ID: 19553700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impaired angiogenesis, delayed wound healing and retarded tumor growth in perlecan heparan sulfate-deficient mice.
    Zhou Z; Wang J; Cao R; Morita H; Soininen R; Chan KM; Liu B; Cao Y; Tryggvason K
    Cancer Res; 2004 Jul; 64(14):4699-702. PubMed ID: 15256433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perlecan heparan sulfate deficiency impairs pulmonary vascular development and attenuates hypoxic pulmonary hypertension.
    Chang YT; Tseng CN; Tannenberg P; Eriksson L; Yuan K; de Jesus Perez VA; Lundberg J; Lengquist M; Botusan IR; Catrina SB; Tran PK; Hedin U; Tran-Lundmark K
    Cardiovasc Res; 2015 Jul; 107(1):20-31. PubMed ID: 25952902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mast cells produce novel shorter forms of perlecan that contain functional endorepellin: a role in angiogenesis and wound healing.
    Jung M; Lord MS; Cheng B; Lyons JG; Alkhouri H; Hughes JM; McCarthy SJ; Iozzo RV; Whitelock JM
    J Biol Chem; 2013 Feb; 288(5):3289-304. PubMed ID: 23235151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant Domain V of Human Perlecan Is a Bioactive Vascular Proteoglycan.
    Rnjak-Kovacina J; Tang F; Lin X; Whitelock JM; Lord MS
    Biotechnol J; 2017 Dec; 12(12):. PubMed ID: 28846206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heparan and chondroitin sulfate on growth plate perlecan mediate binding and delivery of FGF-2 to FGF receptors.
    Smith SM; West LA; Govindraj P; Zhang X; Ornitz DM; Hassell JR
    Matrix Biol; 2007 Apr; 26(3):175-84. PubMed ID: 17169545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perlecan modulates VEGF signaling and is essential for vascularization in endochondral bone formation.
    Ishijima M; Suzuki N; Hozumi K; Matsunobu T; Kosaki K; Kaneko H; Hassell JR; Arikawa-Hirasawa E; Yamada Y
    Matrix Biol; 2012 May; 31(4):234-45. PubMed ID: 22421594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myeloperoxidase-derived oxidants selectively disrupt the protein core of the heparan sulfate proteoglycan perlecan.
    Rees MD; Whitelock JM; Malle E; Chuang CY; Iozzo RV; Nilasaroya A; Davies MJ
    Matrix Biol; 2010 Jan; 29(1):63-73. PubMed ID: 19788922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.